Loi Huriet Sérusclat

hideThis article has multiple issues. Please help or discuss these issues on the talk page. (Learn how and when to remove these template messages) This article needs additional citations for verification. Please help by adding citations to reliable sources. Unsourced material may be challenged and removed. Find sources:  –  ·  ·  · scholar · JSTOR (June 2015) (Learn how and when to remove this template message) This article includes a list of references, related reading or external links, but its sources remain unclear because it lacks inline citations. Please help to improve this article by introducing more precise citations. (June 2015) (Learn how and when to remove this template message) This article is an orphan, as no other articles . Please introduce links to this page from ; try the Find link tool for suggestions. (June 2015) (Learn how and when to remove this template message)

The Loi du 20 décembre 1988 relative à la protection des personnes qui se prêtent à des recherches biomédicales, also known as the Loi Huriet or Loi Huriet-Sérusclat, is a French civil law to establish the regulation of those working in biomedical research, and to formalise the status quo of bioethics. It was proposed under the second government of Michel Rocard (Parti socialiste) six months after the 1988 French legislative election. It was the first French law that put clinical trials on a firm legal footing.

First statute[]

An appendix, IIb, to the French civil code on Public Health, established the (CCPPRB), later succeeded by the (CPP). Its ambit, defined in Article 15, established in law the notion of a consentement éclairé (a "Clear consent", perhaps similar to the Clean hands doctrine in common law), and established penalties for breaking the law.

The common name , and abbreviated variations such as and , come from the names of the nominator and seconder in the French senate, (Centrist) and Franck Sérusclat (Socialist).

Evolution[]

As cases came to court with the usual jurisprudence,^{[Note 1]} public perception of the importance of bioethics and other European Union law, have supplemented the powers made under the original regulatory framework, such as French: ("Law of 29 July 1994, Respect of the human body"), which defined the legal notion of dignity, and ("Law of 4 March 2002, Patient rights and the quality of health system").

Notes[]

References[]

• Defert, Daniel (1994). "La loi Huriet et le point de vue des malades". In ; Ghanassia, J.-P.; Lemaire, F. (eds.). Consentement éclairé et recherche clinique [Huriet Law and the point of view of those with illness] (in French). Paris: Flammarion. pp. 22–25.

This article relating to the law of France is a stub. You can help Wikipedia by .

• v
• t